Extreme genetic risk for type 1A diabetes

被引:162
|
作者
Aly, Theresa A.
Ide, Akane
Jahromi, Mohamed M.
Barker, Jennifer M.
Fernando, Maria S.
Babu, Sunanda R.
Yu, Liping
Miao, Dongmei
Erlich, Henry A.
Fain, Pamela R.
Barriga, Katherine J.
Norris, Jill M.
Rewers, Marian J.
Eisenbarth, George S. [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA
[2] Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Aurora, CO 80045 USA
[3] Roche Mol Syst, Alameda, CA 94501 USA
[4] Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80262 USA
[5] Hlth Sci Ctr, Denver, CO 80262 USA
关键词
haplotype; human leukocyte antigen; major histocompatibility complex;
D O I
10.1073/pnas.0606349103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Type 1 A diabetes (T1D) is an autoimmune disorder the risk of which is increased by specific HLA DR/DQ alleles [e.g., DRB1*03-DQB1*0201 (DR3) or DRB1*04-DQB1*0302 (DR4)]. The genotype associated with the highest risk for T1D is the DR3/4-DQ8 (DQ8 is DQA1*0301, DQB1*0302) heterozygous genotype. We determined HLA-DR and -DQ genotypes at birth and analyzed DR3/4-DQ8 siblings of patients with T1D for identical-by-descent HLA haplotype sharing (the number of haplotypes inherited in common between siblings). The children were clinically followed with prospective measurement of anti-islet autoimmunity and for progression to T1D. Risk for islet autoimmunity dramatically increased in DR3/4-DQ8 siblings who shared both HLA haplotypes with their diabetic proband sibling (63% by age 7, and 85% by age 15) compared with siblings who did not share both HLA haplotypes with their diabetic proband sibling (20% by age 15, P < 0.01). 55% sharing both HILA haplotypes developed diabetes by age 12 versus 5% sharing zero or one haplotype (P = 0.03). Despite sharing both HILA haplotypes with their proband, siblings without the HILA DR3/4-DQ8 genotype had only a 25% risk for T1D by age 12. The risk for T1D in the DR3/4-DQ8 siblings sharing both HILA haplotypes with their proband is remarkable for a complex genetic disorder and provides evidence that T1D is inherited with HLA-DR/DQ alleles and additional MHC-linked genes both determining major risk. A subset of siblings at extremely high risk for T1D can now be identified at birth for trials to prevent islet autoimmunity.
引用
收藏
页码:14074 / 14079
页数:6
相关论文
共 50 条
  • [31] Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis
    Maria J. Redondo
    Richard A. Oram
    Andrea K. Steck
    Current Diabetes Reports, 2017, 17
  • [32] Cellular and molecular pathogenesis of type 1A diabetes
    M. M. Jahromi
    G. S. Eisenbarth
    Cellular and Molecular Life Sciences, 2007, 64
  • [33] Cellular and molecular pathogenesis of type 1A diabetes
    Jahromi, M. M.
    Eisenbarth, G. S.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (7-8) : 865 - 872
  • [34] Genetics of Type 1A (immune mediated) diabetes
    Melanitou, E
    Fain, P
    Eisenbarth, GS
    JOURNAL OF AUTOIMMUNITY, 2003, 21 (02) : 93 - 98
  • [35] Autoimmune diseases in type 1A diabetes mellitus
    Ferreira-Hermosillo, Aldo
    Antonio Molina-Ayala, Mario
    REVISTA MEDICA DE CHILE, 2015, 143 (08) : 1042 - 1049
  • [36] Type 1A diabetes induced by infection and immunization
    Robles, DT
    Eisenbarth, GS
    JOURNAL OF AUTOIMMUNITY, 2001, 16 (03) : 355 - 362
  • [37] The stages of Type 1A diabetes: Retrospective and prospective
    Eisenbarth, GS
    DIABETES NUTRITION & METABOLISM, 2004, 17 (06) : 374 - 385
  • [38] Do cardiovascular disease (CVD) risk factors cluster in youth with type 1A or type 2 diabetes?
    Mayer-Davis, Elizabeth J.
    Ma, Bo
    Lawson, Andrew
    D'Agostino, Ralph B., Jr.
    Liese, Angela D.
    Bell, Ronny A.
    DIABETES, 2006, 55 : A220 - A221
  • [39] Intervention trials for type 1A diabetes: Strategies to maximize sensitivity of detecting disease risk
    Pietropaolo, M
    Laporte, R
    Pietropaolo, S
    Riley, K
    Zhang, YJ
    Darnley, A
    Swanson, P
    Trucco, M
    Becker, D
    DIABETES, 2002, 51 : A288 - A288
  • [40] Utilizing long-range genomic identity to assess type 1A diabetes risk
    Johnson, Kelly
    Baschal, Erin
    Jasinski, Jean
    CLINICAL IMMUNOLOGY, 2008, 127 : S101 - S101